299 related articles for article (PubMed ID: 9283990)
1. Cisapride in the long-term treatment of chronic gastroparesis: a 2-year open-label study.
Kendall BJ; Kendall ET; Soykan I; McCallum RW
J Int Med Res; 1997; 25(4):182-9. PubMed ID: 9283990
[TBL] [Abstract][Full Text] [Related]
2. Effect of cisapride on gastric dysrhythmia and emptying of indigestible solids in type-II diabetic patients.
Chang CS; Lien HC; Yeh HZ; Poon SK; Tung CF; Chen GH
Scand J Gastroenterol; 1998 Jun; 33(6):600-4. PubMed ID: 9669631
[TBL] [Abstract][Full Text] [Related]
3. Double blind controlled trial of effect of cisapride on gastric emptying in diabetics.
Dutta U; Padhy AK; Ahuja V; Sharma MP
Trop Gastroenterol; 1999; 20(3):116-9. PubMed ID: 10695417
[TBL] [Abstract][Full Text] [Related]
4. Comparative effects of levosulpiride and cisapride on gastric emptying and symptoms in patients with functional dyspepsia and gastroparesis.
Mansi C; Borro P; Giacomini M; Biagini R; Mele MR; Pandolfo N; Savarino V
Aliment Pharmacol Ther; 2000 May; 14(5):561-9. PubMed ID: 10792119
[TBL] [Abstract][Full Text] [Related]
5. Glucose control is not improved by accelerating gastric emptying in patients with type 1 diabetes mellitus and gastroparesis. a pilot study with cisapride as a model drug.
Lehmann R; Honegger RA; Feinle C; Fried M; Spinas GA; Schwizer W
Exp Clin Endocrinol Diabetes; 2003 Aug; 111(5):255-61. PubMed ID: 12951630
[TBL] [Abstract][Full Text] [Related]
6. Use of metoclopramide, domperidone, and cisapride in the management of diabetic gastroparesis.
Brown CK; Khanderia U
Clin Pharm; 1990 May; 9(5):357-65. PubMed ID: 2190745
[TBL] [Abstract][Full Text] [Related]
7. Domperidone is more effective than cisapride in children with diabetic gastroparesis.
Franzese A; Borrelli O; Corrado G; Rea P; Di Nardo G; Grandinetti AL; Dito L; Cucchiara S
Aliment Pharmacol Ther; 2002 May; 16(5):951-7. PubMed ID: 11966504
[TBL] [Abstract][Full Text] [Related]
8. [Influence on glycemic control of improved diabetic gastroparesis by long-term cisapride therapy].
Ishii K; Tanabe S; Mitsuhashi T; Saigenji K
Nihon Shokakibyo Gakkai Zasshi; 1995 Oct; 92(10):1724-33. PubMed ID: 7474464
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of gastric emptying and motility in diabetic gastroparesis with magnetic resonance imaging: effects of cisapride.
Borovicka J; Lehmann R; Kunz P; Fraser R; Kreiss C; Crelier G; Boesiger P; Spinas GA; Fried M; Schwizer W
Am J Gastroenterol; 1999 Oct; 94(10):2866-73. PubMed ID: 10520835
[TBL] [Abstract][Full Text] [Related]
10. Relationship between the effects of cisapride on gastric emptying and plasma glucose concentrations in diabetic gastroparesis.
Horowitz M; Jones KL; Harding PE; Wishart JM
Digestion; 2002; 65(1):41-6. PubMed ID: 11961342
[TBL] [Abstract][Full Text] [Related]
11. Oral mitemcinal (GM-611), an erythromycin-derived prokinetic, accelerates normal and experimentally delayed gastric emptying in conscious dogs.
Onoma M; Yogo K; Ozaki K; Kamei K; Akima M; Koga H; Itoh Z; Omura S; Takanashi H
Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):35-42. PubMed ID: 18047625
[TBL] [Abstract][Full Text] [Related]
12. Open label study of long-term effectiveness of cisapride in patients with idiopathic gastroparesis.
Dworkin BM; Rosenthal WS; Casellas AR; Girolomo R; Lebovics E; Freeman S; Clark SB
Dig Dis Sci; 1994 Jul; 39(7):1395-8. PubMed ID: 8026248
[TBL] [Abstract][Full Text] [Related]
13. Long-term efficacy of oral cisapride in symptomatic upper gut dysmotility.
Abell TL; Camilleri M; DiMagno EP; Hench VS; Zinsmeister AR; Malagelada JR
Dig Dis Sci; 1991 May; 36(5):616-20. PubMed ID: 2022163
[TBL] [Abstract][Full Text] [Related]
14. Long-term cisapride treatment improves diabetic gastroparesis but not glycaemic control.
Braden B; Enghofer M; Schaub M; Usadel KH; Caspary WF; Lembcke B
Aliment Pharmacol Ther; 2002 Jul; 16(7):1341-6. PubMed ID: 12144585
[TBL] [Abstract][Full Text] [Related]
15. Prokinetics in patients with gastroparesis: a systematic analysis.
Sturm A; Holtmann G; Goebell H; Gerken G
Digestion; 1999; 60(5):422-7. PubMed ID: 10473966
[TBL] [Abstract][Full Text] [Related]
16. Relamorelin Reduces Vomiting Frequency and Severity and Accelerates Gastric Emptying in Adults With Diabetic Gastroparesis.
Lembo A; Camilleri M; McCallum R; Sastre R; Breton C; Spence S; White J; Currie M; Gottesdiener K; Stoner E;
Gastroenterology; 2016 Jul; 151(1):87-96.e6. PubMed ID: 27055601
[TBL] [Abstract][Full Text] [Related]
17. Objective and subjective results of a randomized, double-blind, placebo-controlled trial using cisapride to treat gastroparesis.
Richards RD; Valenzuela GA; Davenport KG; Fisher KL; McCallum RW
Dig Dis Sci; 1993 May; 38(5):811-6. PubMed ID: 8482178
[TBL] [Abstract][Full Text] [Related]
18. Effect of chronic administration of cisapride on gastric emptying of a solid meal and on dyspeptic symptoms in patients with idiopathic gastroparesis.
Corinaldesi R; Stanghellini V; Raiti C; Rea E; Salgemini R; Barbara L
Gut; 1987 Mar; 28(3):300-5. PubMed ID: 3552906
[TBL] [Abstract][Full Text] [Related]
19. The effect of different dosage schedules of cisapride on gastric emptying in idiopathic gastroparesis.
Corinaldesi R; Stanghellini V; Tosetti C; Rea E; Corbelli C; Marengo M; Monetti N; Barbara L
Eur J Clin Pharmacol; 1993; 44(5):429-32. PubMed ID: 8359178
[TBL] [Abstract][Full Text] [Related]
20. Effect of six weeks of treatment with cisapride in gastroparesis and intestinal pseudoobstruction.
Camilleri M; Malagelada JR; Abell TL; Brown ML; Hench V; Zinsmeister AR
Gastroenterology; 1989 Mar; 96(3):704-12. PubMed ID: 2644150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
